Charles River Laboratories International, Inc.
CRL · NYSE
12/31/2024 | 12/28/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | – | $195 | $277 | $234 |
| Short-Term Investments | – | $0 | $0 | $0 |
| Receivables | – | $721 | $780 | $752 |
| Inventory | – | $279 | $380 | $256 |
| Other Curr. Assets | – | $209 | $171 | $197 |
| Total Curr. Assets | – | $1,403 | $1,609 | $1,439 |
| Property Plant & Equip (Net) | – | $2,017 | $2,034 | $1,857 |
| Goodwill | – | $2,847 | $3,095 | $2,850 |
| Intangibles | – | $723 | $864 | $955 |
| Long-Term Investments | – | $218 | $244 | $312 |
| Tax Assets | – | $42 | $40 | $41 |
| Other NC Assets | – | $278 | $309 | $148 |
| Total NC Assets | – | $6,125 | $6,586 | $6,164 |
| Other Assets | – | $0 | $0 | $0 |
| Total Assets | – | $7,528 | $8,195 | $7,603 |
| Liabilities | – | – | – | – |
| Payables | – | $140 | $169 | $206 |
| Short-Term Debt | – | $0 | $0 | $0 |
| Tax Payable | – | $0 | $39 | $0 |
| Deferred Revenue | – | $248 | $242 | $264 |
| Other Curr. Liab. | – | $605 | $606 | $621 |
| Total Curr. Liab. | – | $994 | $1,055 | $1,092 |
| LT Debt | – | $2,724 | $3,066 | $3,097 |
| Deferred Rev, NC | – | $0 | $0 | $0 |
| Deferred Tax Liab, NC | – | $107 | $191 | $216 |
| Other NC Liab. | – | $195 | $223 | $175 |
| Total NC Liab. | – | $3,026 | $3,481 | $3,488 |
| Other Liabilities | – | $0 | $0 | $0 |
| Cap. Leases | – | $484 | $419 | $390 |
| Total Liabilities | – | $4,020 | $4,536 | $4,579 |
| Equity | – | – | – | – |
| Pref Stock | – | $0 | $0 | $0 |
| Common Stock | – | $1 | $1 | $1 |
| Retained Earnings | – | $1,812 | $1,887 | $1,433 |
| AOCI | – | -$317 | -$196 | -$262 |
| Other Equity | – | $1,966 | $1,906 | $1,805 |
| Total Equity | – | $3,462 | $3,597 | $2,976 |
| Supplemental Information | – | – | – | – |
| Minority Interest | – | $47 | $62 | $47 |
| Total Liab. & Tot. Equity | – | $7,528 | $8,195 | $7,603 |
| Net Debt | $0 | $2,529 | $2,790 | $2,863 |